Adult Subependymoma Completed Phase 1 Trials for Temozolomide (DB00853)

IndicationStatusPhase
DBCOND0029702 (Adult Subependymoma)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01119599RO4929097, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Malignant GliomaTreatment